Irish medical journal 2013-01-01

Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy.

L Wilson, J Sheehan, M Thorpe

Index: Ir. Med. J. 106(1) , 24-5, (2013)

Full Text: HTML

Abstract

Impulse control disorders (ICDs) are a known side effect of dopamine replacement therapy in patients with Parkinson's disease (PD). They can have devastating consequences for patients and their families.

Related Compounds

Structure Name/CAS No. Articles
Selegiline HCl Structure Selegiline HCl
CAS:14611-52-0
E 250 Structure E 250
CAS:2079-54-1
Adamantan-1-amine Structure Adamantan-1-amine
CAS:768-94-5
Ropinirole hydrochloride Structure Ropinirole hydrochloride
CAS:91374-20-8
1-Adamantanamine hydrochloride Structure 1-Adamantanamine hydrochloride
CAS:665-66-7
Carbidopa Structure Carbidopa
CAS:28860-95-9
selegiline Structure selegiline
CAS:14611-51-9
Carbidopa monohydrate Structure Carbidopa monohydrate
CAS:38821-49-7